Medicines/finished pharmaceutical products

Reference Number: 
HA107 (a)

Date of prequalification: 
20 March 2002
Basis of listing: 
Prequalified by WHO
Status: 
Active
INN: 
Abacavir (sulfate)
Therapeutic area: 
HIV/AIDS
Dosage form & strength: 
Solution, Oral 20mg/mL
Storage condition: 
Do not store above 30°C
Shelf life (months): 
24
Packaging: 
Bottle HDPE: 240mL
Applicant: 
ViiV Healthcare, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom of Great Britain and Northern Ireland
FPP Manufacturing Site: 

GlaxoSmithKline, 7333 Mississauga North Road, Mississauga, Ontario, Canada

FPP WHO Public Inspection Reports: 
API Manufacturing Site: 

(Abacavir (sulfate)) Glaxo Operations UK Limited, Cobden Street, Montrose, Angus, DD10 8EA, United Kingdom of Great Britain and Northern Ireland
(Abacavir (sulfate)) Piramal Enterprises Limited, Digwal (Vil), Kohir, Medak, Andra Pradesh, 502 321, India
(Abacavir (sulfate)) SmithKline Beecham Limited, Currabinny, Carrigaline, County Cork, Ireland

API WHO Public Inspection Reports: